If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 307.00
Bid: 301.00
Ask: 310.00
Change: 3.00 (0.99%)
Spread: 9.00 (2.99%)
Open: 307.00
High: 307.00
Low: 307.00
Prev. Close: 304.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Primacy Corporation

27 Feb 2017 07:00

RNS Number : 8550X
Microgen PLC
27 February 2017
 

microgen

www.microgen.com 27 February 2017

 

 

 

ACQUISITION OF PRIMACY CORPORATION

 

Microgen plc ('Microgen') is pleased to announce the acquisition of Primacy Corporation ('Primacy') from the Kelly Family Trust for total cash consideration of CAD5.6 million (Canadian Dollars) (£3.4 million). Primacy is a Toronto-based provider of software to the Trust & Fund Administration market and will be integrated into the Microgen Financial Systems business.

 

Primacy is the fifth acquisition by Microgen since December 2014 and continues the Group's strategy of consolidation in the Trust & Fund Administration market, a global niche within the broader Wealth Management sector. These acquisitions provide Microgen with an increased client and recurring revenue base and complement the organic growth in Microgen 5Series revenues resulting in the Microgen Financial Systems business becoming increasingly focussed on Trust & Fund Administration.

 

Primacy's revenue in the year ending 31 October 2016 was CAD2.0 million (£1.2 million) with profit before tax of CAD0.9 million (£0.6 million). The gross assets at 31 October 2016 were CAD1.2 million (£0.7 million) and it is anticipated that at completion there will be cash and net funds of approximately CAD0.2 million (£0.1 million). The acquisition of Primacy is anticipated to be earnings enhancing in the current financial year and is funded through Microgen's existing cash resources.

 

As previously announced, Microgen expects to announce its preliminary results for the year ending 31 December 2016 on 8 March 2017.

 

Contacts

Philip Wood, Chief Financial Officer 020-7496-8100

 

James Melville-Ross / Darius Alexander 020-3727-1000

FTI Consulting

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBIGDDBUDBGRS
Date   Source Headline
27th Mar 202012:38 pmRNSBlock listing Interim Review
18th Mar 20205:00 pmRNSAnnual Report and Notice of AGM
16th Mar 20201:52 pmRNSBlock Listing Application
13th Mar 20205:11 pmRNSDirector/PDMR Shareholding
11th Mar 20207:00 amRNSAudited Preliminary Results
13th Feb 20205:26 pmRNSHolding(s) in Company
3rd Feb 20201:54 pmRNSTotal Voting Rights
22nd Jan 20202:44 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSTrading Update, Board Changes & Notice of Results
15th Jan 202012:01 pmRNSHolding(s) in Company
3rd Jan 202012:07 pmRNSSecond Price Monitoring Extn
3rd Jan 202012:02 pmRNSPrice Monitoring Extension
3rd Jan 20207:00 amRNSTotal Voting Rights
3rd Dec 20192:52 pmRNSHolding(s) in Company
2nd Dec 201910:28 amRNSTotal Voting Rights
12th Nov 20191:48 pmRNSDirector/PDMR Shareholding
11th Nov 20197:00 amRNSHolding(s) in Company
1st Nov 20197:00 amRNSTotal Voting Rights
29th Oct 20197:00 amRNSAward of Options
23rd Oct 20193:19 pmRNSHolding(s) in Company
4th Oct 20197:00 amRNSChange of Auditor and Partner Programme
30th Sep 20196:03 pmRNSHolding(s) in Company
30th Sep 20197:21 amRNSHolding(s) in Company
27th Sep 20199:35 amRNSHolding(s) in Company
26th Sep 20192:25 pmRNSBlock Listing Interim Review
26th Sep 20198:30 amRNSAcceptance of the B Share Purchase Offer
25th Sep 20198:00 amRNSPurchase Offer for B Shares
24th Sep 20197:00 amRNSIssue of B Shares and Share Consolidation
23rd Sep 20191:50 pmRNSReturn of Value and Result of GM
11th Sep 20196:03 pmRNSHolding(s) in Company
9th Sep 20192:27 pmRNSHolding(s) in Company
9th Sep 20192:13 pmRNSHolding(s) in Company
3rd Sep 20197:00 amRNSPublication of Circular and Notice of GM
2nd Sep 20194:16 pmRNSCorrection: Issue of Consideration Shares
2nd Sep 20191:37 pmRNSConfirmation of Directorate Change
2nd Sep 20197:00 amRNSIssue of Consideration Shares
29th Aug 20191:23 pmRNSHolding(s) in Company
27th Aug 201910:07 amRNSHolding(s) in Company
27th Aug 201910:06 amRNSHolding(s) in Company
14th Aug 20191:08 pmRNSHolding(s) in Company
12th Aug 20194:46 pmRNSHolding(s) in Company
7th Aug 20195:43 pmRNSHolding(s) in Company
6th Aug 201912:56 pmRNSDirector/PDMR Shareholding and Total Voting Rights
1st Aug 20197:00 amRNSTotal Voting Rights
30th Jul 20193:20 pmRNSBlock Listing Application
24th Jul 20197:00 amRNSInterim Results
15th Jul 20197:00 amRNSTrading Update, Board Changes & Notice of Results
12th Jul 20194:53 pmRNSHolding(s) in Company
28th Jun 20191:27 pmRNSCompletion of sale of Microgen Financial Systems
24th Jun 20194:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.